Department of Mechanical and Industrial Engineering, University of Toronto, 5 King's College Road, Toronto, Ontario, M5S 3G8, Canada.
Phys Med Biol. 2018 May 10;63(10):105004. doi: 10.1088/1361-6560/aabd14.
We developed and evaluated a novel inverse optimization (IO) model to estimate objective function weights from clinical dose-volume histograms (DVHs). These weights were used to solve a treatment planning problem to generate 'inverse plans' that had similar DVHs to the original clinical DVHs. Our methodology was applied to 217 clinical head and neck cancer treatment plans that were previously delivered at Princess Margaret Cancer Centre in Canada. Inverse plan DVHs were compared to the clinical DVHs using objective function values, dose-volume differences, and frequency of clinical planning criteria satisfaction. Median differences between the clinical and inverse DVHs were within 1.1 Gy. For most structures, the difference in clinical planning criteria satisfaction between the clinical and inverse plans was at most 1.4%. For structures where the two plans differed by more than 1.4% in planning criteria satisfaction, the difference in average criterion violation was less than 0.5 Gy. Overall, the inverse plans were very similar to the clinical plans. Compared with a previous inverse optimization method from the literature, our new inverse plans typically satisfied the same or more clinical criteria, and had consistently lower fluence heterogeneity. Overall, this paper demonstrates that DVHs, which are essentially summary statistics, provide sufficient information to estimate objective function weights that result in high quality treatment plans. However, as with any summary statistic that compresses three-dimensional dose information, care must be taken to avoid generating plans with undesirable features such as hotspots; our computational results suggest that such undesirable spatial features were uncommon. Our IO-based approach can be integrated into the current clinical planning paradigm to better initialize the planning process and improve planning efficiency. It could also be embedded in a knowledge-based planning or adaptive radiation therapy framework to automatically generate a new plan given a predicted or updated target DVH, respectively.
我们开发并评估了一种新的逆优化 (IO) 模型,以从临床剂量-体积直方图 (DVH) 中估计目标函数权重。这些权重用于解决治疗计划问题,以生成具有与原始临床 DVH 相似的“逆计划”。我们的方法应用于 217 个先前在加拿大玛格丽特公主癌症中心进行的头颈部癌症治疗计划。使用目标函数值、剂量-体积差异和临床计划标准满足频率来比较逆计划 DVH 与临床 DVH。临床和逆 DVH 之间的中位数差异在 1.1Gy 以内。对于大多数结构,临床和逆计划之间在临床计划标准满足方面的差异最大为 1.4%。对于两个计划在规划标准满足方面差异超过 1.4%的结构,平均标准违规差异小于 0.5Gy。总体而言,逆计划与临床计划非常相似。与文献中的先前逆优化方法相比,我们的新逆计划通常满足相同或更多的临床标准,并且具有一致更低的通量异质性。总体而言,本文表明,本质上是摘要统计信息的 DVH 提供了足够的信息来估计导致高质量治疗计划的目标函数权重。然而,与压缩三维剂量信息的任何摘要统计数据一样,必须小心避免生成具有不理想特征(如热点)的计划;我们的计算结果表明,这种不理想的空间特征并不常见。我们的基于 IO 的方法可以集成到当前的临床规划范例中,以更好地初始化规划过程并提高规划效率。它也可以嵌入基于知识的规划或自适应放射治疗框架中,分别根据预测或更新的目标 DVH 自动生成新计划。